Disorders of calcium, phosphorus, and vitamin D metabolism in patients with chronic renal insufficiency stimulate excessive secretion of parathyroid hormone (PTH), leading to secondary hyperparathyroidism (sHPT), which progresses to hyperplasia and adenoma, the most common complications of end-stage renal disease. The gene discussed is PTH; the disease is hyperplasia.